Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -82.38% is 55% below its 5-year average of -53.14%, near the low end of its 5-year range (-105.38%–-11.59%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.71% above its 12-month average of -85.56%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -82.38%.
RETURN ON EQUITY (ROE)
-82.38%
RETURN ON EQUITY (ROE) AVG TTM
-85.56%
RETURN ON EQUITY (ROE) AVG 3Y
-72.06%
RETURN ON EQUITY (ROE) AVG 5Y
-53.14%
RETURN ON EQUITY (ROE) AVG 10Y
-45.90%
RETURN ON EQUITY (ROE) AVG 15Y
-26.00%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.71%
CURRENT VS 3Y AVG
-14.32%
CURRENT VS 5Y AVG
-55.02%
CURRENT VS 10Y AVG
-79.49%
CURRENT VS 15Y AVG
-216.83%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-37.66%
median of 436 covered companies
CURRENT VS SECTOR MEDIAN
-118.76%
vs the sector median at left
Adicet Bio, Inc.
Market Cap
$60.48M
Return on Equity (ROE)
-82.38%
TTM Avg
-85.56%
3Y Avg
-72.06%
5Y Avg
-53.14%
Market Cap
$60.29M
Return on Equity (ROE)
N/A
TTM Avg
-866.00%
3Y Avg
-422.47%
5Y Avg
-312.54%
Market Cap
$60.78M
Return on Equity (ROE)
N/A
TTM Avg
71.44%
3Y Avg
1810.59%
5Y Avg
1190.90%
Market Cap
$61.77M
Return on Equity (ROE)
-76.75%
TTM Avg
-53.49%
3Y Avg
-5.79%
5Y Avg
-19.88%
Market Cap
$58.43M
Return on Equity (ROE)
-58.99%
TTM Avg
-51.19%
3Y Avg
-1.82%
5Y Avg
11.74%
Market Cap
$63.98M
Return on Equity (ROE)
-122.71%
TTM Avg
-558.46%
3Y Avg
-307.41%
5Y Avg
-314.14%
Market Cap
$56.54M
Return on Equity (ROE)
-132.16%
TTM Avg
-74.56%
3Y Avg
-71.32%
5Y Avg
22.85%
Market Cap
$64.56M
Return on Equity (ROE)
-8.80%
TTM Avg
-13.04%
3Y Avg
-7.69%
5Y Avg
-7.21%
Market Cap
$65.08M
Return on Equity (ROE)
N/A
TTM Avg
-26.44%
3Y Avg
-559.66%
5Y Avg
-417.87%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adicet Bio, Inc. (ACET) | $60.48M | -82.38% | -85.56% | -72.06% | -53.14% |
| Fractyl Health, Inc. (GUTS)vs › | $60.29M | N/A | -866.00% | -422.47% | -312.54% |
| MiNK Therapeutics, Inc. (INKT)vs › | $60.78M | N/A | 71.44% | 1810.59% | 1190.90% |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.77M | -76.75% | -53.49% | -5.79% | -19.88% |
| Boundless Bio, Inc. (BOLD)vs › | $58.43M | -58.99% | -51.19% | -1.82% | 11.74% |
| Cingulate Inc. (CING)vs › | $63.98M | -122.71% | -558.46% | -307.41% | -314.14% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $56.54M | -132.16% | -74.56% | -71.32% | 22.85% |
| InterCure Ltd. (INCR)vs › | $64.56M | -8.80% | -13.04% | -7.69% | -7.21% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.08M | N/A | -26.44% | -559.66% | -417.87% |
| Aldeyra The (ALDX)vs › | $55.72M | -60.85% | -77.57% | -56.89% | -53.13% |
ROE
-82.4%
ROA
-66.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -82.38% |
| 2026-03-31 | -77.70% |
| 2025-12-31 | -73.36% |
| 2025-09-30 | -105.38% |
| 2025-06-30 | -88.95% |
| 2025-03-31 | -72.67% |
| 2024-12-31 | -62.76% |
| 2024-09-30 | -55.73% |
| 2024-06-30 | -58.39% |
| 2024-03-31 | -54.02% |
| 2023-12-31 | -83.83% |
| 2023-09-30 | -73.48% |
| 2023-06-30 | -48.17% |
| 2023-03-31 | -39.55% |
| 2022-12-31 | -23.87% |
| 2022-09-30 | -17.54% |
| 2022-06-30 | -16.28% |
| 2022-03-31 | -11.59% |
| 2021-12-31 | -20.45% |
| 2021-09-30 | -25.39% |
| 2021-06-30 | -24.49% |
| 2021-03-31 | -22.65% |
| 2020-12-31 | -33.40% |
| 2020-09-30 | -29.33% |
| 2020-06-30 | -48.48% |
| 2020-03-31 | -37.68% |
| 2019-09-30 | -81.59% |
| 2019-06-30 | -65.53% |
| 2018-12-31 | -95.82% |
| 2018-09-30 | -87.81% |
| 2018-06-30 | -77.60% |
| 2018-03-31 | -39.86% |
| 2017-06-30 | 8.58% |
| 2017-03-31 | 3.71% |
| 2016-12-31 | 4.98% |
| 2016-09-30 | 9.22% |
| 2016-06-30 | 11.00% |
| 2016-03-31 | 12.43% |
| 2015-12-31 | 12.29% |
| 2015-09-30 | 12.62% |
| 2015-06-30 | 11.41% |
| 2015-03-31 | 10.57% |
| 2014-12-31 | 9.36% |
| 2014-09-30 | 9.57% |
| 2014-06-30 | 12.42% |
| 2014-03-31 | 12.91% |
| 2013-12-31 | 14.26% |
| 2013-09-30 | 13.84% |
| 2013-06-30 | 11.47% |
| 2013-03-31 | 11.29% |
| 2012-12-31 | 10.43% |
| 2012-09-30 | 10.81% |
| 2012-06-30 | 10.11% |
| 2012-03-31 | 9.78% |
| 2011-12-31 | 9.26% |
| 2011-09-30 | 5.70% |
| 2011-06-30 | 5.58% |
| 2011-03-31 | 6.11% |
| 2010-12-31 | 6.37% |
| 2010-09-30 | 5.66% |
| 2010-06-30 | 4.71% |
| 2010-03-31 | 2.39% |
| 2009-12-31 | 1.06% |
| 2009-09-30 | 3.51% |
| 2009-06-30 | 6.10% |
| 2009-03-31 | 11.15% |
| 2008-12-31 | 12.07% |
| 2008-09-30 | 11.83% |
